169 related articles for article (PubMed ID: 29282008)
1. Pricing appraisal of anti-cancer drugs in the South East Asian, Western Pacific and East Mediterranean Region.
Salmasi S; Lee KS; Ming LC; Neoh CF; Elrggal ME; Babar ZD; Khan TM; Hadi MA
BMC Cancer; 2017 Dec; 17(1):903. PubMed ID: 29282008
[TBL] [Abstract][Full Text] [Related]
2. Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis.
Iyengar S; Tay-Teo K; Vogler S; Beyer P; Wiktor S; de Joncheere K; Hill S
PLoS Med; 2016 May; 13(5):e1002032. PubMed ID: 27243629
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America.
Moye-Holz D; Vogler S
Appl Health Econ Health Policy; 2022 Jan; 20(1):67-77. PubMed ID: 34228312
[TBL] [Abstract][Full Text] [Related]
5. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.
Vogler S; Vitry A; Babar ZU
Lancet Oncol; 2016 Jan; 17(1):39-47. PubMed ID: 26670089
[TBL] [Abstract][Full Text] [Related]
6. International Price Comparisons of Anticancer Drugs: A Scheme for Improving Patient Accessibility.
Jung JH; Kim DJ; Suh K; You J; Lee JH; Joung KI; Suh DC
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33466893
[TBL] [Abstract][Full Text] [Related]
7. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.
Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F
BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117
[TBL] [Abstract][Full Text] [Related]
8. [Risk sharing methods in middle income countries].
Inotai A; Kaló Z
Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe.
Vokinger KN; Hwang TJ; Daniore P; Lee CC; Tibau A; Grischott T; Rosemann TJ; Kesselheim AS
JAMA Oncol; 2021 Sep; 7(9):e212026. PubMed ID: 34196656
[TBL] [Abstract][Full Text] [Related]
10. Country and regional variations in purchase prices for essential cancer medications.
Cuomo RE; Seidman RL; Mackey TK
BMC Cancer; 2017 Aug; 17(1):566. PubMed ID: 28836947
[TBL] [Abstract][Full Text] [Related]
11. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
[TBL] [Abstract][Full Text] [Related]
12. International price comparisons of Alzheimer's drugs: a way to close the affordability gap.
Suh GH; Wimo A; Gauthier S; O'Connor D; Ikeda M; Homma A; Dominguez J; Yang BM;
Int Psychogeriatr; 2009 Dec; 21(6):1116-26. PubMed ID: 19735595
[TBL] [Abstract][Full Text] [Related]
13. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y; Wang Y; Sun X; Li X
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
[TBL] [Abstract][Full Text] [Related]
14. Determinants of drug prices: a systematic review of comparison studies.
Janssen Daalen JM; den Ambtman A; Van Houdenhoven M; van den Bemt BJF
BMJ Open; 2021 Jul; 11(7):e046917. PubMed ID: 34266841
[TBL] [Abstract][Full Text] [Related]
15. Shortages and price variability of essential cytotoxic medicines for treating children with cancers.
Martei YM; Iwamoto K; Barr RD; Wiernkowski JT; Robertson J
BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33173011
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea.
Hasan SS; Kow CS; Dawoud D; Mohamed O; Baines D; Babar ZU
Value Health Reg Issues; 2019 May; 18():18-23. PubMed ID: 30414506
[TBL] [Abstract][Full Text] [Related]
17. An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012.
Lee JSF; Sagaon Teyssier L; Dongmo Nguimfack B; Collins IJ; Lallemant M; Perriens J; Moatti JP
BMC Pediatr; 2016 Mar; 16():41. PubMed ID: 26979974
[TBL] [Abstract][Full Text] [Related]
18. Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature.
Ocran Mattila P; Ahmad R; Hasan SS; Babar ZU
Front Public Health; 2021; 9():628744. PubMed ID: 33996712
[No Abstract] [Full Text] [Related]
19. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
Babar ZU; Lessing C; Mace C; Bissell K
Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
